Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 50, Issue 5, Pages (November 2006)

Similar presentations


Presentation on theme: "Volume 50, Issue 5, Pages (November 2006)"— Presentation transcript:

1 Volume 50, Issue 5, Pages 1086-1095 (November 2006)
Extended Duration of Efficacy of Vardenafil When Taken 8 Hours Before Intercourse: A Randomized, Double-Blind, Placebo-Controlled Study  Hartmut Porst, Ira D. Sharlip, Dimitris Hatzichristou, Eusebio Rubio-Aurioles, Marc Gittelman, Britt-Nicole Stancil, Peter M. Smith, H. Jeffrey Wilkins, Peter Pommerville  European Urology  Volume 50, Issue 5, Pages (November 2006) DOI: /j.eururo Copyright © 2006 European Association of Urology Terms and Conditions

2 Fig. 1 Patient disposition and reasons for withdrawal.
European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

3 Fig. 2 LS mean success rates for maintaining an erection that led to successful sexual intercourse (SEP3) and inserting the penis into the partner’s vagina (SEP2) at baseline and overall for weeks 2–10 (the period after the initial titration phase). LS=least squares; SEP=Sexual Encounter Profile Question. European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

4 Fig. 3 Overall mean success rates during weeks 2–10 (the period after the initial titration phase) for (1) maintaining an erection that led to successful sexual intercourse (SEP3) and (2) inserting the penis into the partner’s vagina (SEP2) at hourly intervals 6–10hours postdose. SEP=Sexual Encounter Profile Question. European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

5 Fig. 4 LS mean IIEF-EF domain scores at baseline and after the initial titration phase at weeks 2–6, 6–10 and week 10 LOCF (intent-to-treat population). LS=least squares; IIEF-EF=International Index of Erectile Function-Erectile Function; LOCF=last observation carried forward. European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

6 Fig. 5 Percentage of patients with a positive response to the GAQ (“Has the treatment you have been taking over the last 4 weeks improved your erections? (Y/N)”) after the initial titration phase at weeks 2–6, 6–10 and week 10 LOCF (intent-to-treat population). GAQ=Global Assessment Question; LOCF=last observation carried forward. European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions


Download ppt "Volume 50, Issue 5, Pages (November 2006)"

Similar presentations


Ads by Google